4.7 Article

Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesis

Journal

NATURE IMMUNOLOGY
Volume 20, Issue 1, Pages 86-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41590-018-0273-1

Keywords

-

Categories

Funding

  1. Chemotherapy Foundation
  2. NCI [R01 CA187109, R35 CA220499]
  3. Charles H. Revson Senior Fellowship in Biomedical Science
  4. NIH/NCI [K99CA212276]
  5. Follicular Lymphoma Consortium
  6. [LLS-TRP 6457-15]
  7. [LLS SCOR 7012-16]
  8. NATIONAL CANCER INSTITUTE [R35CA220499, K99CA212276] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Germinal center (GC) B cells feature repression of many gene enhancers to establish their characteristic transcriptome. Here we show that conditional deletion of Lsd1 in GCs significantly impaired GC formation, associated with failure to repress immune synapse genes linked to GC exit, which are also direct targets of the transcriptional repressor BCL6. We found that BCL6 directly binds LSD1 and recruits it primarily to intergenic and intronic enhancers. Conditional deletion of Lsd1 suppressed GC hyperplasia caused by constitutive expression of BCL6 and significantly delayed BCL6-driven lymphomagenesis. Administration of catalytic inhibitors of LSD1 had little effect on GC formation or GC-derived lymphoma cells. Using a CRISPR-Cas9 domain screen, we found instead that the LSD1 Tower domain was critical for dependence on LSD1 in GC-derived B cells. These results indicate an essential role for LSD1 in the humoral immune response, where it modulates enhancer function by forming repression complexes with BCL6.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available